cleaved dff45 (Cell Signaling Technology Inc)
Structured Review

Cleaved Dff45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cleaved dff45/product/Cell Signaling Technology Inc
Average 93 stars, based on 10 article reviews
Images
1) Product Images from "GSK3β Inhibition Is the Molecular Pivot That Underlies the Mir-210-Induced Attenuation of Intrinsic Apoptosis Cascade during Hypoxia"
Article Title: GSK3β Inhibition Is the Molecular Pivot That Underlies the Mir-210-Induced Attenuation of Intrinsic Apoptosis Cascade during Hypoxia
Journal: International Journal of Molecular Sciences
doi: 10.3390/ijms23169375
Figure Legend Snippet: miR-210 attenuates the hypoxia-induced increase in DNA fragmentation through the inhibition of GSK3β kinase activity. ( A ) Quantitative TUNEL assay determining apoptotic DNA fragmentation, expressed as experimental blank-corrected absorbances (O.D) measured at λ 450 (450 nm). ( B ) Qualitative Western blot depicting the processing of the DFF45 into cleaved -DFF45 (p11 fragment) as a surrogate measure of caspase-3-induced DFF40 endonuclease activity. ( C ) Quantitative ELISA determining the levels of cleaved -DFF45 (p11 fragment), expressed as experimental blank-corrected absorbance (O.D) measured at λ 570 (570 nm). ( D ) Quantitative DFF40 endonuclease activity assay, expressed as experimental blank-corrected absorbances (O.D) measured at λ 405 (405 nm). miR-210 expression levels in the respective cell lysates were determined by the miR-210 hybridization immunoassay (as described in ) and are reported in . The validation of the ectopic expression of the HA-tagged ca -GSK3β-S9A mutant in the pertinent experimental groups was performed by ELISA immunoassay and is reported in ). GSK3β kinase activity (as described in ) was measured in all experimental groups to corroborate and validate the translative effects of the ectopic expression of the ca -GSK3β-S9A mutant (reported in ). All data are expressed as mean ± S.D from three technical replicates for each of the four biological replicates belonging to each experimental group ( n = 4). ** p ≤ 0.01; **** p ≤ 0.0001; ns: not significant ( p > 0.05). OE: miR-210 overexpression; O.D: optical density; S.D: standard deviation.
Techniques Used: Inhibition, Activity Assay, TUNEL Assay, Western Blot, Enzyme-linked Immunosorbent Assay, Expressing, Hybridization, Biomarker Discovery, Mutagenesis, Over Expression, Standard Deviation
Figure Legend Snippet: List of antibodies and antibody-blocking peptides used in the study.
Techniques Used: Enzyme-linked Immunosorbent Assay, Blocking Assay, Peptide ELISA, Activity Assay
